Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating IncomePreferred Dividend PaymentsProfit After TaxRevenueShares Outstanding (Weighted Average)
Others
Ratios

cbdMD (YCBD) EBITDA (2016 - 2025)

Historic EBITDA for cbdMD (YCBD) over the last 10 years, with Q4 2025 value amounting to -$286288.0.

  • cbdMD's EBITDA fell 23184.35% to -$286288.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.4 million, marking a year-over-year decrease of 114.56%. This contributed to the annual value of -$2.2 million for FY2025, which is 3477.16% up from last year.
  • As of Q4 2025, cbdMD's EBITDA stood at -$286288.0, which was down 23184.35% from -$685816.0 recorded in Q3 2025.
  • cbdMD's 5-year EBITDA high stood at -$86272.0 for Q4 2024, and its period low was -$33.1 million during Q2 2022.
  • In the last 5 years, cbdMD's EBITDA had a median value of -$1.7 million in 2023 and averaged -$6.2 million.
  • Its EBITDA has fluctuated over the past 5 years, first crashed by 132874.11% in 2021, then surged by 9791.97% in 2024.
  • Over the past 5 years, cbdMD's EBITDA (Quarter) stood at -$25.1 million in 2021, then skyrocketed by 83.91% to -$4.0 million in 2022, then skyrocketed by 73.66% to -$1.1 million in 2023, then surged by 91.91% to -$86272.0 in 2024, then crashed by 231.84% to -$286288.0 in 2025.
  • Its EBITDA stands at -$286288.0 for Q4 2025, versus -$685816.0 for Q3 2025 and -$904686.0 for Q2 2025.